-
-
Advertiser’s event preview: Naidex 46
-
31st Jan 2020
-
Posted in Courses & Conferences
- Advertiser's event preview: Naidex 46
-
-
NEURAM2020: Improving neuro-rehabilitative care in Mauritius
-
27th Jan 2020
-
Posted in Courses & Conferences
- Conference details: 27-28 May 2020
-
-
Type 1 Spinal Muscular Atrophy: Risdiplam (RG7916) Pivotal FIREFISH Study Demonstrated Statistically Significant Improvement in Infants
-
23rd Jan 2020
-
Posted in Industry News
- News from PTC therapeutics
-
-
New mobile scanner allows CT images of the head directly on the ICU ward
-
23rd Jan 2020
-
Posted in Industry News
- News from Siemens
-
-
Neurokinex Kids brings breakthrough therapies to children with Cerebral Palsy
-
22nd Jan 2020
-
Posted in Industry News
- Industry news from Neurokinex
-
-
EU approval of Mayzent® (siponimod) for adult patients with secondary progressive multiple sclerosis (SPMS) with active disease
-
21st Jan 2020
-
Posted in Industry News
- News from Novartis on the EU approval of Mayzent (siponimod) for adult patients with SPMS with active disease
-
-
7th Global Symposium on Medical Ketogenic Dietary Therapies
-
21st Jan 2020
-
Posted in Courses & Conferences
- Preview: 7th Global Symposium on Medical Ketogenic Dietary Therapies
-
-
Phase II clinical trial of respiratory drug for treatment of Parkinson’s reveals promising results
-
16th Jan 2020
-
Posted in Industry News,Online First
- News from the Cure Parkinson's Trust
-
-
Ocrelizumab (Ocrevus®) accepted for use in PPMS within NHS Scotland
-
14th Jan 2020
-
Posted in Industry News
- Industry news from Roche
-
-
CONy 2020 – Controversies in Neurology
-
14th Jan 2020
-
Posted in Courses & Conferences
- PREVIEW: Invitation from the organisers of CONy 2020 in London
